Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NCT: NCT06082518 · ACTIVE_NOT_RECRUITING

NCT IDNCT06082518
StatusACTIVE_NOT_RECRUITING
Start Date2024-01-02
Completion2027-07
SponsorSunnybrook Health Sciences Centre (OTHER)
First posted
Last updated

Brief Summary

Over 500 million people have been infected with COVID-19, and to date, more than 6 million people have died. Many individuals who have recovered from COVID-19 continue to experience symptoms even after they have been "cured" of the disease. This condition is known as post COVID-19 condition, which can have serious health consequences. A common symptom among these individuals is chronic fatigue, characterized by persistent tiredness or lack of energy. This study aims to explore a novel treatment for symptoms of post COVID-19 condition, known as hyperbaric oxygen therapy. This approach has shown promise in helping people with post COVID-19 conditions and treating some other causes of fatigue. Hyperbaric oxygen therapy involves placing patients in a small chamber where they receive high oxygen gas levels. However, this treatment is expensive and time-consuming, and it is unclear if this treatment can be effectively assessed in a large-scale research study. This small study will help us decide if conducting a large research study is feasible. The investigators aim to assess if hyperbaric oxygen therapy can improve symptoms of post COVID-19 condition, such as fatigue.

Frequently Asked Questions

What is Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments?

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments is a clinical trial registered under NCT06082518. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06082518?

The current status of NCT06082518 (Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments) is: ACTIVE_NOT_RECRUITING.

When did Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments start?

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments started on 2024-01-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.